Industrial and Commercial Bank of China Limited vs AstraZeneca PLC
μκ°μ λ°λ₯Έ μκ°μ΄μ‘ λΉκ΅
Industrial and Commercial Bank of China Limited
$297.9B
μμ #52
AstraZeneca PLC
$302.7B
μμ #50
μκ°μ λ°λ₯Έ μκ°μ΄μ‘
μ°λλ³ λΉκ΅
| μ°λ | Industrial and Commercial Bank of China Limited | AstraZeneca PLC | μ λ |
|---|---|---|---|
| 2026 | $297.9B | $302.7B | AstraZeneca PLC |
| 2025 | $66.8B | $282.2B | AstraZeneca PLC |
| 2024 | $52.7B | $196.9B | AstraZeneca PLC |
| 2023 | $35.8B | $198.1B | AstraZeneca PLC |
| 2022 | $34.6B | $195.3B | AstraZeneca PLC |
| 2021 | $35.1B | $163.9B | AstraZeneca PLC |
| 2020 | $37.4B | $136.9B | AstraZeneca PLC |
| 2019 | $42.3B | $132.8B | AstraZeneca PLC |
| 2018 | $37.6B | $97.9B | AstraZeneca PLC |
| 2017 | $40.2B | $85.9B | AstraZeneca PLC |
| 2016 | $28.2B | $64.5B | AstraZeneca PLC |
| 2015 | $26.6B | $76.6B | AstraZeneca PLC |
| 2014 | $30.6B | $76.2B | AstraZeneca PLC |
| 2013 | $26.5B | $61.7B | AstraZeneca PLC |
| 2012 | $26.5B | $46.3B | AstraZeneca PLC |
| 2011 | $21.3B | $42.7B | AstraZeneca PLC |
| 2010 | $25.9B | $40.3B | AstraZeneca PLC |
| 2009 | $27.5B | $38.9B | AstraZeneca PLC |
| 2008 | $16.8B | $32.3B | AstraZeneca PLC |
| 2007 | $22.5B | $32.3B | AstraZeneca PLC |
| 2006 | $19.4B | $39.1B | AstraZeneca PLC |